High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.
Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEVâ„¢ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in ...
Explore HIV prevention options for women, including dapivirine rings and dual prevention pills, aiming to reduce infections ...